vimarsana.com
Home
Live Updates
More Evidence That ARSIs for Prostate Cancer Differ in Cogni
More Evidence That ARSIs for Prostate Cancer Differ in Cogni
More Evidence That ARSIs for Prostate Cancer Differ in Cognitive Effects
More fatigue, depression, worse reaction time with enzalutamide as compared with abiraterone
Related Keywords
New York ,
United States ,
Steven Vogl ,
Amit Bahl ,
Charles Bankhead ,
University Hospitals Bristol ,
Genitourinary Cancers ,
New York City ,
Medpage Today ,